Import of Second-Hand and Refurbished Medical Equipment in Iran

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Iran adopts a stance of prohibition in principle, permission by exception toward second-hand and refurbished medical devices: their import is not permitted without the special permission of the Medical Device Commission. The judgment of GRZAN is that the approval rate for such applications is not high, and that the review cycle is unpredictable, so companies should not build it into the baseline scenario of a business plan. The feasible strategy is to assess first and only then decide whether to invest — and the core of the assessment is whether the equipment has absolutely no alternative source within Iran, because that is the question on which the whole application stands or falls. Assessment here means documentary research and market sounding, not an application filed speculatively. A refusal that arrives after months of committee handling is expensive precisely because it was avoidable at the assessment stage. The assessment is cheap; the failed application is not.

  • The import of second-hand and refurbished devices is prohibited in principle, unless the Medical Device Commission grants special permission.
  • The application’s core material is a justification report demonstrating that no alternative source exists within Iran.
  • Equipment condition evidence must be complete: years of use, repair records, calibration reports and original-manufacturer refurbishment certificates submitted as a full set.
  • The approval body for exceptions is the Commission rather than a line department, so the process is collective and case-by-case, with lower predictability of cycle and outcome.
  • Even with the Commission’s special permission, an import can still be stopped at the import registration stage if domestic equivalents exist, because the two procedures are independent.
  • Second-hand equipment applications should be treated as opportunistic projects and never as the baseline scenario of revenue forecasts.
  • The legislative logic of the prohibition is dual: quality that cannot be verified, plus protection of domestic manufacturing.
  • Because the exception is decided collectively, the application should be built to be read by a committee rather than by a single examiner.

2. Legal basis

On the import restriction: the import of second-hand and refurbished devices is prohibited in principle, unless the Medical Device Commission grants special permission. This is documented in public industry material; the Iranian official document number has not been released through public channels, and this is a practical estimate.

The Law on Maximum Utilization of the Country’s Production and Services Capacities in Support of Iranian Goods, adopted in Iranian year 1398 (2019), consisting of 24 articles, applies through Article 1: where similar goods exist within the country, import registration will not be processed. This means a second-hand import that does obtain special permission can still face the ordinary domestic-equivalent blocking rule at the next gate.

The statutory anchor remains the Law Concerning Regulations of Medical, Laboratory, Pharmaceutical and Food and Beverage Affairs, recorded in FAOLEX as LEX-FAOC227692, dated 1955-06-20, Article 3.

3. Expert insights

Insight 1: the legislative logic of the prohibition is double — uncontrollable quality plus domestic protection. The quality state of second-hand equipment is difficult to verify, and at the same time its low price would undercut domestically manufactured equipment. Once this dual logic is understood, the company understands something decisive: the focus of an exception application’s argumentation is not that the equipment is in good condition, but that no alternative can be obtained within Iran. Condition evidence supports the application, but the absence of alternatives is what justifies it. The distinction also explains why a well-documented device in good condition can still be refused, and why refusal is not evidence of a defective file.

Insight 2: the approval body for exceptions is the Commission, not a line department. This means the approval is a collective decision handled case by case, and both the cycle and the outcome are less predictable than on the routine pathways. A project that depends on such an approval cannot be scheduled with ordinary planning confidence, which is precisely why it must not anchor a business plan. Planning assumptions should therefore carry explicit contingency rather than a single expected date. The committee format also means the file must stand on its own, since no examiner carries the applicant’s context into the room.

Insight 3: the restriction stacks with import registration blocking. Even after obtaining the Commission’s special permission, if a domestic equivalent product exists, the consignment may still be stopped at the import registration stage. The two procedures are independent of each other, and there is no effect by which holding the permission automatically clears the import. This stacking is why the domestic-alternative screening must precede the application, not follow it. Planning a second-hand import therefore means passing two independent gates, each with its own evidence set.

4. Practical recommendations

  • Run the domestic alternative research first: produce the justification report demonstrating that no alternative source exists within Iran, and treat it as the core material of the application before any drafting of the application itself.
  • Make the equipment condition evidence complete: submit years of use, repair records, calibration reports and original-manufacturer refurbishment certificates as one full set.
  • Keep it out of the baseline business plan: treat the second-hand equipment application as an opportunistic project, not as the baseline scenario of a revenue forecast.
  • Assess import registration risk in parallel: even with special permission in hand, screen for domestic-equivalent blocking at the same time.

5. Verification checklist

  • □ The justification report demonstrating no alternative source within Iran has been issued
  • □ Years of use, repair records, calibration reports and refurbishment certificates have been assembled
  • □ It has been confirmed that the approval body is the Medical Device Commission and the application follows the case-by-case process
  • □ Domestic-equivalent blocking of import registration has been screened in parallel
  • □ The business plan does not list second-hand equipment imports as a baseline scenario

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iranian market. Our team manages IFDA registration applications, prepares reference-country dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail